Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib

Br J Dermatol. 2015 Oct;173(4):1098-9. doi: 10.1111/bjd.13922. Epub 2015 Sep 1.

Authors

A Fabiano¹, P Calzavara-Pinton², P Monari², E Moggio², G Pellacani¹, A M Manganoni², G Gualdi²

Affiliations

¹ Dermatology Unit, Department of Head and Neck Surgery, Via Del Pozzo 71, Modena, 40124, Italy.
² Dermatology Unit, Department of Dermatology, University Hospital Spedali Civili, Brescia, Italy.

PMID: 25997466
DOI: 10.1111/bjd.13922

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Carcinoma, Squamous Cell / chemically induced*
Drug Eruptions / etiology*
Female
Head and Neck Neoplasms / chemically induced
Humans
Keratoacanthoma / chemically induced*
Nitriles
Primary Myelofibrosis / drug therapy
Protein Kinase Inhibitors / adverse effects*
Pyrazoles / adverse effects*
Pyrimidines
Skin Neoplasms / chemically induced*

Substances

Nitriles
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ruxolitinib